Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 1998

View Archived Issues

Diane-35 now available in Canada for treatment of acne

U.S. patent issued for Maxim's MaxVax technology

LIPID study establishes efficacy of pravastatin in patients with lower cholesterol levels

Vical provides clinical update of Leuvectin in treatment of prostate cancer

Mechanism-of-action studies of nifekalant described

Improved antibacterial efficacy observed with OPC-20011

Microbix and Gensia Sicor terminate licensing agreement

Sonus and Daiichi terminate licensing agreement

AMBI seeks partners to develop oral nisin for H. pylori eradication

FDA approves new indications, dosing regimens for Vantin

Health Canada approves lamivudine for treatment of chronic HBV

CPMP issues positive opinion for E.U. approval of Zenapax

Pfizer announces further product launches for novel quinolone

Preclinical study results indicate feasibility of long-term administration of antihypertensive drug

Inhibitors of neovascularization (angiogenesis) patented by JT

Taisho discloses new antitumor series

Gene therapies for neuromuscular diseases pursued by Transgene and AFM

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Albuterol delivered by novel MSI system enters clinical evaluation

Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease

Novel injectable drug delivery technology in-licensed by Medi-Ject

Isis sublicenses technology for designing improved antisense drugs

Additional dose of 5G1.1-SC for phase IIb CPB study identified in phase I trial

Clinical anti-HIV activity of FTC correlated with intracellular levels of triphosphate

Hydroxyurea-containing salvage regimens for advanced-stage HIV infection

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Advisory committee recommends approval of Celebrex for arthritis and further discussions for pain

Comparison of LT and TxA2 antagonists in asthmatic patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...